The Procter & Gamble Company (NYSE:PG) Stock Position Decreased by Westhampton Capital LLC

Westhampton Capital LLC trimmed its position in shares of The Procter & Gamble Company (NYSE:PG) by 0.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 29,516 shares of the company’s stock after selling 250 shares during the quarter. Procter & Gamble makes up approximately 2.6% of Westhampton Capital LLC’s investment portfolio, making the stock its 4th largest position. Westhampton Capital LLC’s holdings in Procter & Gamble were worth $5,112,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PG. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble in the second quarter valued at approximately $28,000. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. Ruedi Wealth Management Inc. increased its position in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares during the last quarter. POM Investment Strategies LLC purchased a new position in Procter & Gamble during the second quarter worth about $34,000. Finally, Quest Partners LLC acquired a new position in Procter & Gamble in the 2nd quarter valued at about $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 0.1 %

Shares of Procter & Gamble stock opened at $169.73 on Wednesday. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The company has a 50 day moving average of $171.87 and a 200 day moving average of $167.43. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $400.59 billion, a P/E ratio of 29.26, a P/E/G ratio of 3.72 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company’s revenue was down .6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.83 earnings per share. As a group, research analysts forecast that The Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.

Analyst Upgrades and Downgrades

PG has been the subject of a number of recent analyst reports. Citigroup raised their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. TD Cowen assumed coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective for the company. Stifel Nicolaus upped their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Piper Sandler began coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective for the company. Finally, Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jon R. Moeller sold 37,240 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the transaction, the chief executive officer now owns 263,537 shares in the company, valued at $44,508,763.93. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock worth $65,140,718 over the last three months. Insiders own 0.18% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.